Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

PURPOSE: Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II clinical trial (ClinicalTrials.gov identifier: N...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Kluger, Harriet M., Chiang, Veronica, Mahajan, Amit, Zito, Christopher R., Sznol, Mario, Tran, Thuy, Weiss, Sarah A., Cohen, Justine V., Yu, James, Hegde, Upendra, Perrotti, Elizabeth, Anderson, Gail, Ralabate, Amanda, Kluger, Yuval, Wei, Wei, Goldberg, Sarah B., Jilaveanu, Lucia B.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2019
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354772/
https://ncbi.nlm.nih.gov/pubmed/30407895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00204
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires